Efficacy of Ultrasound-guided Internal Jugular Vein Versus Supraclavicular Subclavian Vein Cannulation in Neonates and Infants Less Than 5 kg.

NCT ID: NCT05956028

Last Updated: 2025-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-21

Study Completion Date

2025-03-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the effectiveness and safety of ultrasound- guided IJV and supraclavicular SCV cannulation in infants weighing less than 5 kg.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to compare the effectiveness and safety of ultrasound- guided IJV and supraclavicular SCV cannulation in infants weighing less than 5 kg.

It is hypothesized that ultrasound guided supraclavicular SCV cannulation has a higher success rate compared to IJV cannulation.

Infants will be recruited into the trial during pre-operative assessment. Recruited infants will be randomly assigned to one of two groups in a 1:1 ratio; (group S) to receive ultrasound guided SCV cannulation and (group I) to receive ultrasound guided IJV cannulation. Randomization will be achieved using a computer-generated sequence. Concealment will be achieved using opaque envelopes.

All infants will be anesthetized in accordance with the local policy of pediatric anesthesia unit in Abu El-Reesh pediatric hospital-Cairo university after ethics committee approval.

After preoperative examination and upon arrival to the operating room heart rate, noninvasive blood pressure NBP and oxygen saturation SPO2 will be monitored using standard monitor (drȁger infinity vista XL) before inhalational induction of anesthesia using titration of sevoflurane in oxygen air mixture 60% (starting from 3% up to 8%) until the infant is put to sleep. After securing an intravenous line anesthesia will be completed with 1-2µg/kg of fentanyl and atracurium 0.5 mg/kg.

Induction of anesthesia will be performed by the attending senior anesthesia resident who has finished at least 2 years of residency (who is independent of the study team).

All cannulations will be performed by 2 pediatric anesthesiologists trained in US-guided central line placement each one has performed (more than 50 cannulations) before the study. Catheterization will be performed using a standard Seldinger technique under sterile conditions using high frequency (5-10 MHz) footprint ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA).

Before the procedure, IJV or SCV veins size, patency, and collapsibility with transducer pressure will be assessed using US probe. The cannulation side (right or left) choice and the central venous catheter size will be decided by the practitioner preference according to the patient's vein examination.

Group I:

The standard transverse out-of-plane approach will be used. Infants will be placed in the 10° Trendelenburg and a shoulder roll will be placed to extend the neck, which will be rotated about 30° to the opposite side of cannulation. The transducer will be placed in a transverse position over the patient's neck at the level of cricoid cartilage to identify IJV and common carotid artery (CCA) in short-axis view. The CCA and the IJV will be differentiated by pulsations of the artery and compressibility of the vein. The vein will be then centered on the screen. The skin puncture will be made in the center of the US image using a needle without syringe. The needle will be introduced at an angle of 60° to the skin surface, perpendicular to the transducer. The needle will be advanced toward IJV until an indentation of the anterior wall of the vein is noticed. If spontaneous blood flashback is obtained, the guide wire will be introduced into the vein and the procedure will be completed using Seldinger's technique. If no spontaneous blood return is observed despite clear visualization of the needle bevel in the vessel lumen on US, a syringe will be attached to the needle hub to aspirate blood and then the guide wire will be introduced into the vein and the procedure will be completed. The attempt will be considered successful when smooth insertion of the guidewire into the vein after confirmation of the site of the wire in the right atrium using intraoperative x ray. If blood could not be aspirated, the needle will be withdrawn, the attempt will be considered failed and another attempt will be made to a maximum of 3 attempts. If failure more than 3 attempts, another site will be chosen and the patient will be excluded from the study.

Group S:

The patient will be positioned with the neck extended and rotated 45° opposite to the cannulation side. A towel roll will be placed under the shoulders for adequate neck extension. The US probe will be placed against and above the clavicle to visualize the transversal view of carotid artery and IJV, and then will be slowly tilted against the infant's cheek, showing first the subclavian artery in longitudinal view, and then, more anterior, the SCV, lying on the pleural line.

After obtaining a satisfactory image of the SCV in the longitudinal axis, the needle will be introduced without syringe in an in-plane technique. If spontaneous blood flashback is obtained, the guide wire will be introduced into the vein and the procedure will be completed using Seldinger's technique. If no spontaneous blood return is observed despite clear visualization of the needle bevel in the vessel lumen on US, a syringe will be attached to the needle hub to aspirate blood and then the guide wire will be introduced into the vein and the procedure will be completed. The attempt will be considered successful when smooth insertion of the guidewire into the vein after confirmation of the site of the wire in the right atrium using intraoperative x ray. If blood could not be aspirated, the needle will be withdrawn, the attempt will be considered failed and another attempt will be made. If failure more than 3 attempts, another site will be chosen, and the patient will be excluded from the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Anesthesia Central Venous Catheter Ultrasound Internal Jugular Vein

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

(group S)

receive ultrasound guided subclavian vein cannulation

Group Type EXPERIMENTAL

Ultrasound guided SCV cannulation

Intervention Type PROCEDURE

receive ultrasound guided SCV cannulation

Ultrasound guided IJV cannulation

Intervention Type PROCEDURE

receive ultrasound guided IJV cannulation

(group I)

receive ultrasound guided internal jugular vein cannulation

Group Type ACTIVE_COMPARATOR

Ultrasound guided SCV cannulation

Intervention Type PROCEDURE

receive ultrasound guided SCV cannulation

Ultrasound guided IJV cannulation

Intervention Type PROCEDURE

receive ultrasound guided IJV cannulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound guided SCV cannulation

receive ultrasound guided SCV cannulation

Intervention Type PROCEDURE

Ultrasound guided IJV cannulation

receive ultrasound guided IJV cannulation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • All infants weighing less than 5 kg scheduled for major elective surgeries under general anesthesia.

Exclusion Criteria

* • Parents or legally authorized personnel refusal.

* Previous trials of central venous cannulation in the last week.
* Emergency surgery.
* Coagulopathy (platelets less than 20.000 and or INR more than 1.5)
* Infection at the proposed site for cannulation.
* Inability to visualize vein correctly by the ultrasound.
* Neck deformity or swelling in the proposed site of cannulation.
Minimum Eligible Age

1 Day

Maximum Eligible Age

12 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kasr El Aini Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Khaled Abdelfattah Abdallah Sarhan

principal investigator, Asst. professor of anesthesia, Cairo university

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Khaled Sarhan

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo university hospitals

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MD-159-2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ultrasound-Guided BCV and IJV in ICU Patients
NCT07062068 NOT_YET_RECRUITING NA